Table 5.
Associations of DDTs (Log Base 2 ng/g Lipids) with Liver Fat Attenuation and Fatty Liver (n = 134 Subjects)
| change in liver-to-spleen attenuation (HU) per doubled DDTs | odds of fatty liver per doubled DDTs | |||||
|---|---|---|---|---|---|---|
| slope | 95% CI | p-value | odds ratio | 95% CI | p-value | |
| model 11 | −0.035 | (−0.062, −0.009) | 0.009 | 1.40 | (1.07, 1.85) | 0.01 | 
| model 22 | −0.051 | (−0.082, −0.020) | 0.001 | 1.66 | (1.11, 2.50) | 0.01 | 
| model 33 | −0.042 | (−0.074, −0.010) | 0.01 | 1.52 | (1.0001, 2.30) | 0.0499 | 
Model 1: simple model of DDTs and outcomes.
Model 2: adjusted by confounding variables (age, sex, years in the US, education attainment (less than or completed high school, less than a bachelors degree, holding a bachelors degree, and more than a bachelors degree), and fish protein).
Model 2 plus BMI categories: adjusted by age, sex, years in the US, education attainment (less than or completed high school, less than a bachelors degree, holding a bachelors degree, and more than a bachelors degree), fish protein, and obesity/overweight/normal (by BMI >27.5, 27.5–23, or <23 kg/m2, respectively). Note that we adjusted by BMI categories rather than waist circumference categories to maximize sample size.